Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
2004 StandoutScience
Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma
2008
Androgens and erythropoiesis: Past and present
2009
Magnetic Resonance Imaging in Parkinsonism
1992
The Role of Tea in Human Health: An Update
2002
The β-Thalassemias
1999 Standout
Haemochromatosis in the new millenium
2000
Hereditary Hemochromatosis — A New Look at an Old Disease
2004
Evaluation of iron overload
2004
Iron Overload Cardiomyopathy
2010
Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma
2005
Material differentiation by dual energy CT: initial experience
2006 Standout
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Clinical application of therapeutic erythrocytapheresis (TEA)
2000
Tea Polyphenols as Nutraceuticals
2008
Hemochromatosis—Neonatal and Young Subjects
2002
Clinical aspects of hemochromatosis
2000
In situmeasurement of iron overload in liver tissue by dual-energy methods
1996
Discovery of curcumin, a component of golden spice, and its miraculous biological activities
2011 Standout
Suppression of the hepcidin‐encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase‐2/TMPRSS6
2009 StandoutNobel
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Diagnostic Criteria for Parkinson Disease
1999 Standout
Tannic acid inhibits in vitro iron-dependent free radical formation
2006
Oxidative stress in Parkinson's disease
2003 Standout
Bendamustine is effective therapy in patients with rituximab‐refractory, indolent B‐cell non‐Hodgkin lymphoma
2009
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
NF-κB and IKK as therapeutic targets in cancer
2006 Standout
A moderate transfusion regimen may reduce iron loading in beta‐ thalassemia major without producing excessive expansion of erythropoiesis
1997
Haemochromatosis
2018
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Natural history of juvenile haemochromatosis
2002
Sickle-cell disease
2010 Standout
Beneficial Effects of Green Tea—A Review
2006 Standout
Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point
2013 Standout
Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways
2008 Standout
Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation
2001
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda
2001 Standout
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Disorders of Iron Metabolism
1999 Standout
Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease
2003
Juvenile Hemochromatosis Locus Maps to Chromosome 1q
1999
Juvenile hemochromatosis
2002
Curcumin: From ancient medicine to current clinical trials
2008 Standout
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper
2010
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications
2015 Standout
Neonatal hemochromatosis
1986
Bendamustine: Rebirth of an Old Drug
2009
Limitations of Magnetic Resonance Imaging in Measurement of Hepatic Iron
1997
Human Parvovirus B19
2002 Standout
Management of Hemochromatosis
1998
How I treat Waldenström macroglobulinemia
2015
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
2003 Standout
How I treat hemochromatosis
2010
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients
2005
Juvenile and adult hemochromatosis are distinct genetic disorders.
1998
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
Iron-Chelating Therapy and the Treatment of Thalassemia
1997
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of K.P. Schalk being referenced
Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis
1998
Non‐invasive quantitation of liver iron‐overload by magnetic resonance imaging
1990
Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma
2002
Moderate Dose Escalation for Advanced Stage Hodgkin’s Disease Using the Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Scheme and Adjuvant Radiotherapy: A Study of the German Hodgkin’s Lymphoma Study Group
1998
Juvenile idiopathic haemochromatosis: A life-threatening disorder presenting as hypogonadotropic hypogonadism
1983
Effect of androgens on the response to antithymocyte globulin in patients with aplastic anaemia
1988
Juvenile Hemochromatosis
1988
Bendamustine Plus Rituximab Versus CHOP Plus Rituximab in the First-Line Treatment of Patients with Indolent and Mantle Cell Lymphomas - First Interim Results of a Randomized Phase III Study of the StiL (Study Group Indolent Lymphomas, Germany).
2007